129 related articles for article (PubMed ID: 35020665)
1. Complementary Utility of Dopamine Transporter and Tau PET Imaging in the Diagnosis of Progressive Supranuclear Palsy: A Case Report.
Jia C; Wu M; Yen TC; Li Y; Cui R
Clin Nucl Med; 2022 Apr; 47(4):336-338. PubMed ID: 35020665
[TBL] [Abstract][Full Text] [Related]
2. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
[TBL] [Abstract][Full Text] [Related]
3. Tau imaging with [
Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of
Li L; Liu FT; Li M; Lu JY; Sun YM; Liang X; Bao W; Chen QS; Li XY; Zhou XY; Guan Y; Wu JJ; Yen TC; Jang MK; Luo JF; Wang J; Zuo C;
Mov Disord; 2021 Oct; 36(10):2314-2323. PubMed ID: 34089275
[TBL] [Abstract][Full Text] [Related]
5. Subcortical
Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
[TBL] [Abstract][Full Text] [Related]
7. In vivo binding of a tau imaging probe, [
Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
[TBL] [Abstract][Full Text] [Related]
9. Increased basal ganglia binding of
Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
[TBL] [Abstract][Full Text] [Related]
10. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
[TBL] [Abstract][Full Text] [Related]
11. Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy.
Hammes J; Bischof GN; Giehl K; Faber J; Drzezga A; Klockgether T; van Eimeren T
Mov Disord; 2017 Jan; 32(1):170-171. PubMed ID: 27476874
[No Abstract] [Full Text] [Related]
12. Neuroimaging-pathological correlations of [
Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
[TBL] [Abstract][Full Text] [Related]
13. Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis.
Jin J; Su D; Zhang J; Li X; Feng T
J Neurol; 2023 May; 270(5):2451-2467. PubMed ID: 36633672
[TBL] [Abstract][Full Text] [Related]
14. Subregional Pattern of Striatal Dopamine Transporter Loss on 18F FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing.
Han S; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Park HK; Kim JS
JAMA Neurol; 2016 Dec; 73(12):1477-1484. PubMed ID: 27723878
[TBL] [Abstract][Full Text] [Related]
15.
Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
[TBL] [Abstract][Full Text] [Related]
16. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
17.
Liu FT; Lu JY; Li XY; Liang XN; Jiao FY; Ge JJ; Wu P; Li G; Shen B; Wu B; Sun YM; Zhu YH; Luo JF; Yen TC; Wu JJ; Zuo CT; Wang J;
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1395-1405. PubMed ID: 36627498
[TBL] [Abstract][Full Text] [Related]
18. Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [
Aghakhanyan G; Rullmann M; Rumpf J; Schroeter ML; Scherlach C; Patt M; Brendel M; Koglin N; Stephens AW; Classen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):103-114. PubMed ID: 36048259
[TBL] [Abstract][Full Text] [Related]
19. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies.
Ferschmann C; Messerschmidt K; Gnörich J; Barthel H; Marek K; Palleis C; Katzdobler S; Stockbauer A; Fietzek U; Finze A; Biechele G; Rumpf JJ; Saur D; Schroeter ML; Rullmann M; Beyer L; Eckenweber F; Wall S; Schildan A; Patt M; Stephens A; Classen J; Bartenstein P; Seibyl J; Franzmeier N; Levin J; Höglinger GU; Sabri O; Brendel M; Scheifele M;
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1909-1922. PubMed ID: 38366196
[TBL] [Abstract][Full Text] [Related]
20. The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
López-Mora DA; Fernández León A; Lleó A; Blesa R; Camacho V
Clin Nucl Med; 2020 May; 45(5):e239-e240. PubMed ID: 32149810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
